Cellebrite DI (CLBT) Cash from Operations (2020 - 2026)

Cellebrite DI has reported Cash from Operations for 7 years, with the latest figure at $17.6 million in Q2 2026.

• On a quarterly basis, Cash from Operations fell 46.02% year-over-year to $17.6 million in Q2 2026; TTM through Jun 2026 was $157.6 million, a 2.19% decrease from a year earlier, with the FY2025 full-year figure at $173.5 million, up 31.3% from the prior year.
• Cash from Operations was $17.6 million for Q2 2026 at Cellebrite DI, down from $19.9 million in the prior quarter.
• The five-year high for Cash from Operations was $86.8 million in Q4 2025, with the low at -$10.5 million in Q1 2022.
• Average Cash from Operations over 5 years is $25.9 million, with a median of $20.4 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations slumped 8397.58% in 2022, then surged 5347.84% in 2023.
• Over 5 years, Cash from Operations stood at $35.7 million in 2022, then gained by 22.62% to $43.8 million in 2023, then surged by 50.51% to $66.0 million in 2024, then soared by 31.6% to $86.8 million in 2025, then plunged by 79.74% to $17.6 million in 2026.
• The last three Cash from Operations figures came in at $17.6 million (Q2 2026), $19.9 million (Q1 2026), and $86.8 million (Q4 2025), per Business Quant data.